Predictors and Outcomes of Atrial Fibrillation Progression in Patients with Device-Detected Subclinical AF: Insights from the ARTESiA Trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

4 More presentations in this session

Presentation thumbnail

Catheter ablation in persistent atrial fibrillation: long term outcomes of the CAPLA multicentre randomised trial of pulmonary vein isolation(PVI) vs PVI plus posterior left atrial wall isolation(PWI)

Doctor P. Kistler (Melbourne, AU)

Presentation thumbnail

Randomized evaluation of decision support interventions for atrial fibrillation: Anticoagulant adherence after shared decision making interventions for stroke prevention in atrial fibrillation

Professor E. Jackson (Birmingham, US)

Presentation thumbnail

Biomolecule-based prediction of sinus rhythm and interaction with early rhythm control: EAST-AFNET 4 biomolecule study

Professor L. Fabritz (Hamburg, DE)

Presentation thumbnail

The Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation Extend

Doctor A. Tang (London, CA)

Access the full session

Session thumbnail

Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Session

Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment

Congress Session

Subclinical and device-detected atrial fibrillation: fact and fiction

Congress Presentation

What is the evidence for anticoagulation in subclinical atrial fibrillation detection?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources